nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—liver cancer	0.228	1	CrCtD
Epirubicin—Anthracyclines—Doxorubicin—liver cancer	0.185	0.657	CiPCiCtD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—liver cancer	0.0966	0.343	CiPCiCtD
Epirubicin—stomach cancer—liver cancer	0.0589	0.374	CtDrD
Epirubicin—pancreatic cancer—liver cancer	0.0549	0.348	CtDrD
Epirubicin—Valrubicin—Doxorubicin—liver cancer	0.0486	0.333	CrCrCtD
Epirubicin—Idarubicin—Doxorubicin—liver cancer	0.0486	0.333	CrCrCtD
Epirubicin—Daunorubicin—Doxorubicin—liver cancer	0.0486	0.333	CrCrCtD
Epirubicin—sarcoma—liver cancer	0.0438	0.278	CtDrD
Epirubicin—AURKA—Doxorubicin—liver cancer	0.0392	0.302	CbGbCtD
Epirubicin—YWHAG—Doxorubicin—liver cancer	0.0392	0.302	CbGbCtD
Epirubicin—DHCR7—Doxorubicin—liver cancer	0.0392	0.302	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—liver cancer	0.00796	0.0613	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—liver cancer	0.00441	0.034	CbGbCtD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—liver cancer	0.000245	0.344	CbGdCrCtD
Epirubicin—CHD1—Idarubicin—Doxorubicin—liver cancer	0.000245	0.344	CbGdCrCtD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—liver cancer	8.06e-05	0.113	CbGdCrCtD
Epirubicin—AURKA—Idarubicin—Doxorubicin—liver cancer	8.06e-05	0.113	CbGdCrCtD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—liver cancer	3.08e-05	0.0432	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—liver cancer	3.08e-05	0.0432	CbGdCrCtD
Epirubicin—Creatinine increased—Doxorubicin—liver cancer	2.25e-05	0.000565	CcSEcCtD
Epirubicin—Bone pain—Doxorubicin—liver cancer	2.24e-05	0.000561	CcSEcCtD
Epirubicin—Anaphylactic shock—Sorafenib—liver cancer	2.24e-05	0.000561	CcSEcCtD
Epirubicin—Infection—Sorafenib—liver cancer	2.22e-05	0.000557	CcSEcCtD
Epirubicin—Atrioventricular block—Doxorubicin—liver cancer	2.21e-05	0.000554	CcSEcCtD
Epirubicin—Inflammation—Doxorubicin—liver cancer	2.21e-05	0.000554	CcSEcCtD
Epirubicin—Shock—Sorafenib—liver cancer	2.2e-05	0.000552	CcSEcCtD
Epirubicin—Gait disturbance—Doxorubicin—liver cancer	2.2e-05	0.000551	CcSEcCtD
Epirubicin—Nervous system disorder—Sorafenib—liver cancer	2.2e-05	0.00055	CcSEcCtD
Epirubicin—Thrombocytopenia—Sorafenib—liver cancer	2.19e-05	0.000549	CcSEcCtD
Epirubicin—Blood uric acid increased—Doxorubicin—liver cancer	2.19e-05	0.000548	CcSEcCtD
Epirubicin—Coordination abnormal—Doxorubicin—liver cancer	2.19e-05	0.000548	CcSEcCtD
Epirubicin—Skin disorder—Sorafenib—liver cancer	2.18e-05	0.000545	CcSEcCtD
Epirubicin—Musculoskeletal pain—Doxorubicin—liver cancer	2.17e-05	0.000544	CcSEcCtD
Epirubicin—Neck pain—Doxorubicin—liver cancer	2.17e-05	0.000544	CcSEcCtD
Epirubicin—Phosphatase alkaline increased—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Vaginal inflammation—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Pulmonary embolism—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Hiccups—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Ventricular tachycardia—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Hepatocellular injury—Doxorubicin—liver cancer	2.15e-05	0.000538	CcSEcCtD
Epirubicin—Anorexia—Sorafenib—liver cancer	2.13e-05	0.000535	CcSEcCtD
Epirubicin—Injection site reaction—Doxorubicin—liver cancer	2.13e-05	0.000535	CcSEcCtD
Epirubicin—Dermatitis contact—Doxorubicin—liver cancer	2.12e-05	0.000531	CcSEcCtD
Epirubicin—Abnormal dreams—Doxorubicin—liver cancer	2.12e-05	0.000531	CcSEcCtD
Epirubicin—Hyperkalaemia—Doxorubicin—liver cancer	2.11e-05	0.000528	CcSEcCtD
Epirubicin—Eructation—Doxorubicin—liver cancer	2.11e-05	0.000528	CcSEcCtD
Epirubicin—Cystitis noninfective—Doxorubicin—liver cancer	2.1e-05	0.000525	CcSEcCtD
Epirubicin—Melaena—Doxorubicin—liver cancer	2.1e-05	0.000525	CcSEcCtD
Epirubicin—Influenza like illness—Doxorubicin—liver cancer	2.08e-05	0.000522	CcSEcCtD
Epirubicin—Salivary hypersecretion—Doxorubicin—liver cancer	2.08e-05	0.000522	CcSEcCtD
Epirubicin—Cystitis—Doxorubicin—liver cancer	2.07e-05	0.000519	CcSEcCtD
Epirubicin—Colitis—Doxorubicin—liver cancer	2.06e-05	0.000516	CcSEcCtD
Epirubicin—Candida infection—Doxorubicin—liver cancer	2.05e-05	0.000513	CcSEcCtD
Epirubicin—Skin exfoliation—Doxorubicin—liver cancer	2.05e-05	0.000513	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Sorafenib—liver cancer	2.04e-05	0.000511	CcSEcCtD
Epirubicin—Fluid retention—Doxorubicin—liver cancer	2.04e-05	0.000511	CcSEcCtD
Epirubicin—Blood urea increased—Doxorubicin—liver cancer	2.03e-05	0.000508	CcSEcCtD
Epirubicin—Vaginal infection—Doxorubicin—liver cancer	2.03e-05	0.000508	CcSEcCtD
Epirubicin—Aplastic anaemia—Doxorubicin—liver cancer	2.02e-05	0.000505	CcSEcCtD
Epirubicin—Neuropathy—Doxorubicin—liver cancer	2.02e-05	0.000505	CcSEcCtD
Epirubicin—Dyspnoea—Sorafenib—liver cancer	2e-05	0.0005	CcSEcCtD
Epirubicin—Dry eye—Doxorubicin—liver cancer	1.98e-05	0.000497	CcSEcCtD
Epirubicin—Cramps of lower extremities—Doxorubicin—liver cancer	1.97e-05	0.000494	CcSEcCtD
Epirubicin—Dyspepsia—Sorafenib—liver cancer	1.97e-05	0.000494	CcSEcCtD
Epirubicin—Coma—Doxorubicin—liver cancer	1.96e-05	0.000491	CcSEcCtD
Epirubicin—Oesophagitis—Doxorubicin—liver cancer	1.96e-05	0.000491	CcSEcCtD
Epirubicin—Rash maculo-papular—Doxorubicin—liver cancer	1.95e-05	0.000489	CcSEcCtD
Epirubicin—Decreased appetite—Sorafenib—liver cancer	1.95e-05	0.000488	CcSEcCtD
Epirubicin—Bladder pain—Doxorubicin—liver cancer	1.94e-05	0.000486	CcSEcCtD
Epirubicin—Neoplasm—Doxorubicin—liver cancer	1.94e-05	0.000486	CcSEcCtD
Epirubicin—Mouth ulceration—Doxorubicin—liver cancer	1.94e-05	0.000486	CcSEcCtD
Epirubicin—Ecchymosis—Doxorubicin—liver cancer	1.94e-05	0.000486	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Sorafenib—liver cancer	1.93e-05	0.000484	CcSEcCtD
Epirubicin—Fatigue—Sorafenib—liver cancer	1.93e-05	0.000484	CcSEcCtD
Epirubicin—Pain—Sorafenib—liver cancer	1.91e-05	0.00048	CcSEcCtD
Epirubicin—Constipation—Sorafenib—liver cancer	1.91e-05	0.00048	CcSEcCtD
Epirubicin—Pulmonary oedema—Doxorubicin—liver cancer	1.91e-05	0.000479	CcSEcCtD
Epirubicin—Hypertonia—Doxorubicin—liver cancer	1.88e-05	0.000471	CcSEcCtD
Epirubicin—Abnormal vision—Doxorubicin—liver cancer	1.87e-05	0.000469	CcSEcCtD
Epirubicin—Mental disability—Doxorubicin—liver cancer	1.86e-05	0.000467	CcSEcCtD
Epirubicin—Sepsis—Doxorubicin—liver cancer	1.86e-05	0.000467	CcSEcCtD
Epirubicin—Gastrointestinal pain—Sorafenib—liver cancer	1.83e-05	0.000459	CcSEcCtD
Epirubicin—Lymphadenopathy—Doxorubicin—liver cancer	1.83e-05	0.000458	CcSEcCtD
Epirubicin—Phlebitis—Doxorubicin—liver cancer	1.81e-05	0.000453	CcSEcCtD
Epirubicin—Thrombophlebitis—Doxorubicin—liver cancer	1.8e-05	0.000451	CcSEcCtD
Epirubicin—Diabetes mellitus—Doxorubicin—liver cancer	1.79e-05	0.000449	CcSEcCtD
Epirubicin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	1.79e-05	0.000449	CcSEcCtD
Epirubicin—Hepatic function abnormal—Doxorubicin—liver cancer	1.78e-05	0.000447	CcSEcCtD
Epirubicin—Urticaria—Sorafenib—liver cancer	1.78e-05	0.000446	CcSEcCtD
Epirubicin—Photosensitivity—Doxorubicin—liver cancer	1.77e-05	0.000445	CcSEcCtD
Epirubicin—Daunorubicin—CYP1A1—liver cancer	1.77e-05	1	CrCbGaD
Epirubicin—Abdominal pain—Sorafenib—liver cancer	1.77e-05	0.000444	CcSEcCtD
Epirubicin—Body temperature increased—Sorafenib—liver cancer	1.77e-05	0.000444	CcSEcCtD
Epirubicin—Vascular purpura—Doxorubicin—liver cancer	1.74e-05	0.000436	CcSEcCtD
Epirubicin—Eczema—Doxorubicin—liver cancer	1.73e-05	0.000434	CcSEcCtD
Epirubicin—Hepatic failure—Doxorubicin—liver cancer	1.73e-05	0.000434	CcSEcCtD
Epirubicin—Eye pain—Doxorubicin—liver cancer	1.73e-05	0.000432	CcSEcCtD
Epirubicin—Cardiac failure congestive—Doxorubicin—liver cancer	1.72e-05	0.00043	CcSEcCtD
Epirubicin—Renal failure acute—Doxorubicin—liver cancer	1.69e-05	0.000423	CcSEcCtD
Epirubicin—Hot flush—Doxorubicin—liver cancer	1.67e-05	0.000417	CcSEcCtD
Epirubicin—Increased appetite—Doxorubicin—liver cancer	1.66e-05	0.000416	CcSEcCtD
Epirubicin—Menopausal symptoms—Doxorubicin—liver cancer	1.65e-05	0.000414	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Doxorubicin—liver cancer	1.65e-05	0.000414	CcSEcCtD
Epirubicin—Hypersensitivity—Sorafenib—liver cancer	1.65e-05	0.000413	CcSEcCtD
Epirubicin—Renal impairment—Doxorubicin—liver cancer	1.64e-05	0.00041	CcSEcCtD
Epirubicin—Dermatitis bullous—Doxorubicin—liver cancer	1.63e-05	0.000408	CcSEcCtD
Epirubicin—Purpura—Doxorubicin—liver cancer	1.62e-05	0.000405	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Doxorubicin—liver cancer	1.61e-05	0.000403	CcSEcCtD
Epirubicin—Asthenia—Sorafenib—liver cancer	1.61e-05	0.000403	CcSEcCtD
Epirubicin—Hypoglycaemia—Doxorubicin—liver cancer	1.6e-05	0.0004	CcSEcCtD
Epirubicin—Cardiac failure—Doxorubicin—liver cancer	1.6e-05	0.0004	CcSEcCtD
Epirubicin—Cerebrovascular accident—Doxorubicin—liver cancer	1.59e-05	0.000398	CcSEcCtD
Epirubicin—Lethargy—Doxorubicin—liver cancer	1.59e-05	0.000398	CcSEcCtD
Epirubicin—Pruritus—Sorafenib—liver cancer	1.58e-05	0.000397	CcSEcCtD
Epirubicin—Hyponatraemia—Doxorubicin—liver cancer	1.56e-05	0.000392	CcSEcCtD
Epirubicin—Osteoarthritis—Doxorubicin—liver cancer	1.56e-05	0.00039	CcSEcCtD
Epirubicin—Pain in extremity—Doxorubicin—liver cancer	1.56e-05	0.00039	CcSEcCtD
Epirubicin—Diplopia—Doxorubicin—liver cancer	1.56e-05	0.00039	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	1.56e-05	0.00039	CcSEcCtD
Epirubicin—Migraine—Doxorubicin—liver cancer	1.53e-05	0.000384	CcSEcCtD
Epirubicin—Affect lability—Doxorubicin—liver cancer	1.53e-05	0.000384	CcSEcCtD
Epirubicin—Diarrhoea—Sorafenib—liver cancer	1.53e-05	0.000384	CcSEcCtD
Epirubicin—Face oedema—Doxorubicin—liver cancer	1.5e-05	0.000377	CcSEcCtD
Epirubicin—Cardiac arrest—Doxorubicin—liver cancer	1.48e-05	0.000371	CcSEcCtD
Epirubicin—Dizziness—Sorafenib—liver cancer	1.48e-05	0.000371	CcSEcCtD
Epirubicin—Mood swings—Doxorubicin—liver cancer	1.48e-05	0.00037	CcSEcCtD
Epirubicin—Ataxia—Doxorubicin—liver cancer	1.46e-05	0.000367	CcSEcCtD
Epirubicin—Blood creatinine increased—Doxorubicin—liver cancer	1.46e-05	0.000366	CcSEcCtD
Epirubicin—Dehydration—Doxorubicin—liver cancer	1.45e-05	0.000363	CcSEcCtD
Epirubicin—Liver function test abnormal—Doxorubicin—liver cancer	1.44e-05	0.00036	CcSEcCtD
Epirubicin—Dry skin—Doxorubicin—liver cancer	1.43e-05	0.000358	CcSEcCtD
Epirubicin—Vomiting—Sorafenib—liver cancer	1.42e-05	0.000357	CcSEcCtD
Epirubicin—Orthostatic hypotension—Doxorubicin—liver cancer	1.42e-05	0.000357	CcSEcCtD
Epirubicin—Abdominal pain upper—Doxorubicin—liver cancer	1.42e-05	0.000357	CcSEcCtD
Epirubicin—Hypokalaemia—Doxorubicin—liver cancer	1.42e-05	0.000355	CcSEcCtD
Epirubicin—Rash—Sorafenib—liver cancer	1.41e-05	0.000354	CcSEcCtD
Epirubicin—Dermatitis—Sorafenib—liver cancer	1.41e-05	0.000353	CcSEcCtD
Epirubicin—Breast disorder—Doxorubicin—liver cancer	1.41e-05	0.000353	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	1.4e-05	0.000352	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	1.4e-05	0.000352	CcSEcCtD
Epirubicin—Headache—Sorafenib—liver cancer	1.4e-05	0.000352	CcSEcCtD
Epirubicin—Nasopharyngitis—Doxorubicin—liver cancer	1.39e-05	0.000349	CcSEcCtD
Epirubicin—Gastritis—Doxorubicin—liver cancer	1.38e-05	0.000345	CcSEcCtD
Epirubicin—Muscular weakness—Doxorubicin—liver cancer	1.37e-05	0.000344	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Doxorubicin—liver cancer	1.37e-05	0.000344	CcSEcCtD
Epirubicin—Abdominal distension—Doxorubicin—liver cancer	1.36e-05	0.00034	CcSEcCtD
Epirubicin—Dysphagia—Doxorubicin—liver cancer	1.35e-05	0.000337	CcSEcCtD
Epirubicin—Asthma—Doxorubicin—liver cancer	1.35e-05	0.000337	CcSEcCtD
Epirubicin—Influenza—Doxorubicin—liver cancer	1.35e-05	0.000337	CcSEcCtD
Epirubicin—Eosinophilia—Doxorubicin—liver cancer	1.33e-05	0.000334	CcSEcCtD
Epirubicin—Nausea—Sorafenib—liver cancer	1.33e-05	0.000333	CcSEcCtD
Epirubicin—Pancreatitis—Doxorubicin—liver cancer	1.32e-05	0.000331	CcSEcCtD
Epirubicin—Angina pectoris—Doxorubicin—liver cancer	1.31e-05	0.000329	CcSEcCtD
Epirubicin—Bronchitis—Doxorubicin—liver cancer	1.29e-05	0.000324	CcSEcCtD
Epirubicin—Pancytopenia—Doxorubicin—liver cancer	1.28e-05	0.00032	CcSEcCtD
Epirubicin—Neutropenia—Doxorubicin—liver cancer	1.26e-05	0.000316	CcSEcCtD
Epirubicin—Dysuria—Doxorubicin—liver cancer	1.26e-05	0.000316	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Doxorubicin—liver cancer	1.25e-05	0.000314	CcSEcCtD
Epirubicin—Pollakiuria—Doxorubicin—liver cancer	1.24e-05	0.000312	CcSEcCtD
Epirubicin—Photosensitivity reaction—Doxorubicin—liver cancer	1.23e-05	0.000308	CcSEcCtD
Epirubicin—Weight increased—Doxorubicin—liver cancer	1.23e-05	0.000307	CcSEcCtD
Epirubicin—Weight decreased—Doxorubicin—liver cancer	1.22e-05	0.000305	CcSEcCtD
Epirubicin—Hyperglycaemia—Doxorubicin—liver cancer	1.21e-05	0.000304	CcSEcCtD
Epirubicin—Pneumonia—Doxorubicin—liver cancer	1.21e-05	0.000303	CcSEcCtD
Epirubicin—Infestation—Doxorubicin—liver cancer	1.2e-05	0.000301	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—liver cancer	1.2e-05	0.000301	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—liver cancer	1.2e-05	0.000301	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	1.19e-05	0.000298	CcSEcCtD
Epirubicin—Renal failure—Doxorubicin—liver cancer	1.18e-05	0.000296	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—liver cancer	1.18e-05	0.000295	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—liver cancer	1.17e-05	0.000293	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—liver cancer	1.17e-05	0.000293	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—liver cancer	1.17e-05	0.000292	CcSEcCtD
Epirubicin—Urinary tract infection—Doxorubicin—liver cancer	1.17e-05	0.000292	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—liver cancer	1.15e-05	0.000288	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—liver cancer	1.14e-05	0.000287	CcSEcCtD
Epirubicin—Hepatobiliary disease—Doxorubicin—liver cancer	1.14e-05	0.000285	CcSEcCtD
Epirubicin—Epistaxis—Doxorubicin—liver cancer	1.13e-05	0.000284	CcSEcCtD
Epirubicin—Sinusitis—Doxorubicin—liver cancer	1.13e-05	0.000282	CcSEcCtD
Epirubicin—Agranulocytosis—Doxorubicin—liver cancer	1.12e-05	0.000281	CcSEcCtD
Epirubicin—Bradycardia—Doxorubicin—liver cancer	1.1e-05	0.000275	CcSEcCtD
Epirubicin—Haemoglobin—Doxorubicin—liver cancer	1.08e-05	0.000271	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—liver cancer	1.08e-05	0.000271	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—liver cancer	1.08e-05	0.00027	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—liver cancer	1.08e-05	0.00027	CcSEcCtD
Epirubicin—Hypoaesthesia—Doxorubicin—liver cancer	1.07e-05	0.000269	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—liver cancer	1.07e-05	0.000268	CcSEcCtD
Epirubicin—Urinary tract disorder—Doxorubicin—liver cancer	1.06e-05	0.000267	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—liver cancer	1.06e-05	0.000266	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—liver cancer	1.06e-05	0.000265	CcSEcCtD
Epirubicin—Urethral disorder—Doxorubicin—liver cancer	1.06e-05	0.000265	CcSEcCtD
Epirubicin—Visual impairment—Doxorubicin—liver cancer	1.04e-05	0.00026	CcSEcCtD
Epirubicin—Erythema multiforme—Doxorubicin—liver cancer	1.02e-05	0.000255	CcSEcCtD
Epirubicin—Eye disorder—Doxorubicin—liver cancer	1.01e-05	0.000252	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—liver cancer	1e-05	0.000252	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—liver cancer	1e-05	0.000251	CcSEcCtD
Epirubicin—Cardiac disorder—Doxorubicin—liver cancer	1e-05	0.000251	CcSEcCtD
Epirubicin—Angiopathy—Doxorubicin—liver cancer	9.78e-06	0.000245	CcSEcCtD
Epirubicin—Immune system disorder—Doxorubicin—liver cancer	9.74e-06	0.000244	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—liver cancer	9.71e-06	0.000243	CcSEcCtD
Epirubicin—Chills—Doxorubicin—liver cancer	9.67e-06	0.000242	CcSEcCtD
Epirubicin—Arrhythmia—Doxorubicin—liver cancer	9.63e-06	0.000241	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—liver cancer	9.52e-06	0.000239	CcSEcCtD
Epirubicin—Mental disorder—Doxorubicin—liver cancer	9.44e-06	0.000237	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—liver cancer	9.38e-06	0.000235	CcSEcCtD
Epirubicin—Malnutrition—Doxorubicin—liver cancer	9.38e-06	0.000235	CcSEcCtD
Epirubicin—Flatulence—Doxorubicin—liver cancer	9.25e-06	0.000232	CcSEcCtD
Epirubicin—Tension—Doxorubicin—liver cancer	9.21e-06	0.000231	CcSEcCtD
Epirubicin—Dysgeusia—Doxorubicin—liver cancer	9.19e-06	0.00023	CcSEcCtD
Epirubicin—Nervousness—Doxorubicin—liver cancer	9.11e-06	0.000228	CcSEcCtD
Epirubicin—Back pain—Doxorubicin—liver cancer	9.08e-06	0.000227	CcSEcCtD
Epirubicin—Muscle spasms—Doxorubicin—liver cancer	9.02e-06	0.000226	CcSEcCtD
Epirubicin—Vision blurred—Doxorubicin—liver cancer	8.84e-06	0.000222	CcSEcCtD
Epirubicin—Ill-defined disorder—Doxorubicin—liver cancer	8.71e-06	0.000218	CcSEcCtD
Epirubicin—Anaemia—Doxorubicin—liver cancer	8.67e-06	0.000217	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—liver cancer	8.62e-06	0.000216	CcSEcCtD
Epirubicin—Malaise—Doxorubicin—liver cancer	8.46e-06	0.000212	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—liver cancer	8.43e-06	0.000211	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—liver cancer	8.41e-06	0.000211	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—liver cancer	8.4e-06	0.00021	CcSEcCtD
Epirubicin—Palpitations—Doxorubicin—liver cancer	8.29e-06	0.000208	CcSEcCtD
Epirubicin—Loss of consciousness—Doxorubicin—liver cancer	8.25e-06	0.000207	CcSEcCtD
Epirubicin—Cough—Doxorubicin—liver cancer	8.19e-06	0.000205	CcSEcCtD
Epirubicin—Convulsion—Doxorubicin—liver cancer	8.13e-06	0.000204	CcSEcCtD
Epirubicin—Hypertension—Doxorubicin—liver cancer	8.1e-06	0.000203	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—liver cancer	7.99e-06	0.0002	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—liver cancer	7.99e-06	0.0002	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—liver cancer	7.99e-06	0.0002	CcSEcCtD
Epirubicin—Anxiety—Doxorubicin—liver cancer	7.96e-06	0.000199	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.93e-06	0.000199	CcSEcCtD
Epirubicin—Discomfort—Doxorubicin—liver cancer	7.89e-06	0.000198	CcSEcCtD
Epirubicin—Dry mouth—Doxorubicin—liver cancer	7.81e-06	0.000196	CcSEcCtD
Epirubicin—Confusional state—Doxorubicin—liver cancer	7.72e-06	0.000193	CcSEcCtD
Epirubicin—Anaphylactic shock—Doxorubicin—liver cancer	7.66e-06	0.000192	CcSEcCtD
Epirubicin—Oedema—Doxorubicin—liver cancer	7.66e-06	0.000192	CcSEcCtD
Epirubicin—Infection—Doxorubicin—liver cancer	7.61e-06	0.000191	CcSEcCtD
Epirubicin—Shock—Doxorubicin—liver cancer	7.53e-06	0.000189	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—liver cancer	7.51e-06	0.000188	CcSEcCtD
Epirubicin—Thrombocytopenia—Doxorubicin—liver cancer	7.5e-06	0.000188	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—liver cancer	7.47e-06	0.000187	CcSEcCtD
Epirubicin—Skin disorder—Doxorubicin—liver cancer	7.44e-06	0.000186	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—liver cancer	7.4e-06	0.000185	CcSEcCtD
Epirubicin—Anorexia—Doxorubicin—liver cancer	7.3e-06	0.000183	CcSEcCtD
Epirubicin—Hypotension—Doxorubicin—liver cancer	7.16e-06	0.000179	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.98e-06	0.000175	CcSEcCtD
Epirubicin—Insomnia—Doxorubicin—liver cancer	6.93e-06	0.000174	CcSEcCtD
Epirubicin—Paraesthesia—Doxorubicin—liver cancer	6.88e-06	0.000172	CcSEcCtD
Epirubicin—Dyspnoea—Doxorubicin—liver cancer	6.83e-06	0.000171	CcSEcCtD
Epirubicin—Somnolence—Doxorubicin—liver cancer	6.81e-06	0.000171	CcSEcCtD
Epirubicin—Dyspepsia—Doxorubicin—liver cancer	6.74e-06	0.000169	CcSEcCtD
Epirubicin—Decreased appetite—Doxorubicin—liver cancer	6.66e-06	0.000167	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Doxorubicin—liver cancer	6.61e-06	0.000166	CcSEcCtD
Epirubicin—Fatigue—Doxorubicin—liver cancer	6.6e-06	0.000165	CcSEcCtD
Epirubicin—Pain—Doxorubicin—liver cancer	6.55e-06	0.000164	CcSEcCtD
Epirubicin—Constipation—Doxorubicin—liver cancer	6.55e-06	0.000164	CcSEcCtD
Epirubicin—Feeling abnormal—Doxorubicin—liver cancer	6.31e-06	0.000158	CcSEcCtD
Epirubicin—Gastrointestinal pain—Doxorubicin—liver cancer	6.26e-06	0.000157	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—GSTA4—liver cancer	6.09e-06	0.000377	CbGpPWpGaD
Epirubicin—Urticaria—Doxorubicin—liver cancer	6.08e-06	0.000152	CcSEcCtD
Epirubicin—Body temperature increased—Doxorubicin—liver cancer	6.05e-06	0.000152	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—liver cancer	6.05e-06	0.000152	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	6.02e-06	0.000373	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CG—liver cancer	6.01e-06	0.000373	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	6.01e-06	0.000373	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—liver cancer	6e-06	0.000372	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTA4—liver cancer	5.97e-06	0.00037	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.96e-06	0.000369	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTA2—liver cancer	5.93e-06	0.000368	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.9e-06	0.000366	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.83e-06	0.000362	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—liver cancer	5.82e-06	0.000361	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTA2—liver cancer	5.82e-06	0.000361	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—liver cancer	5.8e-06	0.00036	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPARG—liver cancer	5.8e-06	0.00036	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CYCS—liver cancer	5.77e-06	0.000358	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTA1—liver cancer	5.72e-06	0.000355	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	5.71e-06	0.000354	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—liver cancer	5.68e-06	0.000352	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NAT2—liver cancer	5.66e-06	0.000351	CbGpPWpGaD
Epirubicin—Hypersensitivity—Doxorubicin—liver cancer	5.64e-06	0.000141	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—liver cancer	5.62e-06	0.000349	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTA1—liver cancer	5.61e-06	0.000348	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.61e-06	0.000348	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.56e-06	0.000345	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NAT2—liver cancer	5.55e-06	0.000344	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CPT1B—liver cancer	5.5e-06	0.000341	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GLUL—liver cancer	5.5e-06	0.000341	CbGpPWpGaD
Epirubicin—Asthenia—Doxorubicin—liver cancer	5.49e-06	0.000138	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—liver cancer	5.48e-06	0.00034	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALDOB—liver cancer	5.42e-06	0.000336	CbGpPWpGaD
Epirubicin—Pruritus—Doxorubicin—liver cancer	5.42e-06	0.000136	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MAPK14—liver cancer	5.41e-06	0.000336	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND1—liver cancer	5.36e-06	0.000333	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—liver cancer	5.34e-06	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.34e-06	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDOB—liver cancer	5.32e-06	0.00033	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NR1H4—liver cancer	5.3e-06	0.000329	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CD—liver cancer	5.28e-06	0.000328	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—F2—liver cancer	5.24e-06	0.000325	CbGpPWpGaD
Epirubicin—Diarrhoea—Doxorubicin—liver cancer	5.24e-06	0.000131	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ALB—liver cancer	5.22e-06	0.000324	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTA3—liver cancer	5.21e-06	0.000323	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—liver cancer	5.19e-06	0.000322	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CRABP1—liver cancer	5.18e-06	0.000321	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.11e-06	0.000317	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ALDOB—liver cancer	5.08e-06	0.000315	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CRABP1—liver cancer	5.08e-06	0.000315	CbGpPWpGaD
Epirubicin—Dizziness—Doxorubicin—liver cancer	5.06e-06	0.000127	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—PIK3CG—liver cancer	5.02e-06	0.000311	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.02e-06	0.000311	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—liver cancer	5.02e-06	0.000311	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—liver cancer	4.97e-06	0.000308	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.94e-06	0.000307	CbGpPWpGaD
Epirubicin—Vomiting—Doxorubicin—liver cancer	4.87e-06	0.000122	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—FST—liver cancer	4.86e-06	0.000302	CbGpPWpGaD
Epirubicin—Rash—Doxorubicin—liver cancer	4.83e-06	0.000121	CcSEcCtD
Epirubicin—Dermatitis—Doxorubicin—liver cancer	4.82e-06	0.000121	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.82e-06	0.000299	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—liver cancer	4.81e-06	0.000298	CbGpPWpGaD
Epirubicin—Headache—Doxorubicin—liver cancer	4.8e-06	0.00012	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GSTA4—liver cancer	4.77e-06	0.000296	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—liver cancer	4.66e-06	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.66e-06	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTA2—liver cancer	4.65e-06	0.000288	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TRIO—liver cancer	4.64e-06	0.000288	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CB—liver cancer	4.61e-06	0.000286	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.57e-06	0.000283	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.55e-06	0.000282	CbGpPWpGaD
Epirubicin—Nausea—Doxorubicin—liver cancer	4.55e-06	0.000114	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—HPGDS—liver cancer	4.52e-06	0.000281	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTA1—liver cancer	4.48e-06	0.000278	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR4—liver cancer	4.45e-06	0.000276	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—liver cancer	4.44e-06	0.000275	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HPGDS—liver cancer	4.44e-06	0.000275	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAT2—liver cancer	4.43e-06	0.000275	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CD—liver cancer	4.41e-06	0.000274	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.41e-06	0.000274	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—liver cancer	4.4e-06	0.000273	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—liver cancer	4.36e-06	0.000271	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—liver cancer	4.36e-06	0.00027	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCE—liver cancer	4.34e-06	0.000269	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—liver cancer	4.3e-06	0.000267	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.26e-06	0.000264	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDOB—liver cancer	4.25e-06	0.000264	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—liver cancer	4.2e-06	0.00026	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.18e-06	0.000259	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—liver cancer	4.06e-06	0.000252	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CRABP1—liver cancer	4.06e-06	0.000251	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PPARA—liver cancer	4.05e-06	0.000251	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSMA4—liver cancer	4.03e-06	0.00025	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSMD10—liver cancer	4.03e-06	0.00025	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.02e-06	0.000249	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADAM17—liver cancer	4.01e-06	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.97e-06	0.000246	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSMD10—liver cancer	3.95e-06	0.000245	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSMA4—liver cancer	3.95e-06	0.000245	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RAF1—liver cancer	3.94e-06	0.000244	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—liver cancer	3.93e-06	0.000244	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT2—liver cancer	3.92e-06	0.000243	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT2—liver cancer	3.85e-06	0.000239	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CB—liver cancer	3.85e-06	0.000239	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CSF2—liver cancer	3.84e-06	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMA4—liver cancer	3.77e-06	0.000234	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMD10—liver cancer	3.77e-06	0.000234	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—liver cancer	3.75e-06	0.000233	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.72e-06	0.00023	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2E1—liver cancer	3.69e-06	0.000229	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT2—liver cancer	3.67e-06	0.000228	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.65e-06	0.000226	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—liver cancer	3.63e-06	0.000225	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2E1—liver cancer	3.62e-06	0.000224	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HPGDS—liver cancer	3.54e-06	0.00022	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—liver cancer	3.53e-06	0.000219	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—liver cancer	3.53e-06	0.000219	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.52e-06	0.000219	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADAM17—liver cancer	3.52e-06	0.000218	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.5e-06	0.000217	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYCS—liver cancer	3.45e-06	0.000214	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GGT1—liver cancer	3.39e-06	0.00021	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT1—liver cancer	3.39e-06	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYCS—liver cancer	3.38e-06	0.00021	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	3.36e-06	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT1—liver cancer	3.32e-06	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GGT1—liver cancer	3.32e-06	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMD10—liver cancer	3.31e-06	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMA4—liver cancer	3.31e-06	0.000205	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.21e-06	0.000199	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.17e-06	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT1—liver cancer	3.17e-06	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMA4—liver cancer	3.16e-06	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMD10—liver cancer	3.16e-06	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT2—liver cancer	3.07e-06	0.000191	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTP1—liver cancer	3.04e-06	0.000189	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	3.01e-06	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—liver cancer	3.01e-06	0.000187	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—liver cancer	3.01e-06	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—liver cancer	3e-06	0.000186	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—liver cancer	3e-06	0.000186	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—liver cancer	2.98e-06	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—liver cancer	2.94e-06	0.000182	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCE—liver cancer	2.92e-06	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2E1—liver cancer	2.89e-06	0.000179	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—liver cancer	2.88e-06	0.000179	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—liver cancer	2.81e-06	0.000174	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.8e-06	0.000173	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—liver cancer	2.79e-06	0.000173	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—liver cancer	2.76e-06	0.000171	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—liver cancer	2.74e-06	0.00017	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	2.72e-06	0.000169	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYCS—liver cancer	2.7e-06	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT1—liver cancer	2.65e-06	0.000165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GGT1—liver cancer	2.65e-06	0.000165	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A1—liver cancer	2.65e-06	0.000164	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A1—liver cancer	2.6e-06	0.000161	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCE—liver cancer	2.56e-06	0.000159	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—liver cancer	2.55e-06	0.000158	CbGpPWpGaD
Epirubicin—ABCC1—Disease—H2AFX—liver cancer	2.55e-06	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CD—liver cancer	2.53e-06	0.000157	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—liver cancer	2.47e-06	0.000153	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—liver cancer	2.47e-06	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—liver cancer	2.43e-06	0.00015	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARA—liver cancer	2.42e-06	0.00015	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—liver cancer	2.42e-06	0.00015	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—liver cancer	2.38e-06	0.000148	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARA—liver cancer	2.38e-06	0.000147	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—liver cancer	2.35e-06	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—liver cancer	2.34e-06	0.000145	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—liver cancer	2.31e-06	0.000143	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—liver cancer	2.3e-06	0.000143	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—liver cancer	2.29e-06	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—liver cancer	2.27e-06	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2—liver cancer	2.27e-06	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RAF1—liver cancer	2.26e-06	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—H2AFX—liver cancer	2.23e-06	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CB—liver cancer	2.21e-06	0.000137	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—liver cancer	2.19e-06	0.000136	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—liver cancer	2.17e-06	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.13e-06	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A1—liver cancer	2.08e-06	0.000129	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—liver cancer	2.08e-06	0.000129	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—liver cancer	2.03e-06	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—liver cancer	2.03e-06	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—liver cancer	2.02e-06	0.000125	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—liver cancer	2e-06	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—liver cancer	1.96e-06	0.000122	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—liver cancer	1.94e-06	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—liver cancer	1.94e-06	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—liver cancer	1.92e-06	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARA—liver cancer	1.9e-06	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—liver cancer	1.85e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK14—liver cancer	1.83e-06	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—liver cancer	1.82e-06	0.000113	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CD—liver cancer	1.82e-06	0.000113	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—liver cancer	1.8e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ESR1—liver cancer	1.8e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CD—liver cancer	1.79e-06	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—liver cancer	1.78e-06	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—liver cancer	1.77e-06	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CD—liver cancer	1.71e-06	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.71e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—liver cancer	1.7e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—liver cancer	1.7e-06	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—liver cancer	1.69e-06	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—liver cancer	1.63e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—liver cancer	1.6e-06	9.92e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CB—liver cancer	1.59e-06	9.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—liver cancer	1.57e-06	9.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CB—liver cancer	1.56e-06	9.67e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RAF1—liver cancer	1.52e-06	9.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CD—liver cancer	1.5e-06	9.28e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTOR—liver cancer	1.49e-06	9.23e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CB—liver cancer	1.49e-06	9.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—liver cancer	1.48e-06	9.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—liver cancer	1.46e-06	9.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CD—liver cancer	1.43e-06	8.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—liver cancer	1.41e-06	8.75e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—liver cancer	1.4e-06	8.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—liver cancer	1.35e-06	8.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAF1—liver cancer	1.34e-06	8.28e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—liver cancer	1.32e-06	8.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTOR—liver cancer	1.3e-06	8.09e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CB—liver cancer	1.3e-06	8.09e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—liver cancer	1.29e-06	7.99e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CB—liver cancer	1.25e-06	7.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—liver cancer	1.24e-06	7.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—liver cancer	1.22e-06	7.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—liver cancer	1.2e-06	7.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—liver cancer	1.2e-06	7.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—liver cancer	1.19e-06	7.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—liver cancer	1.17e-06	7.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUN—liver cancer	1.16e-06	7.22e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—liver cancer	1.16e-06	7.17e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—liver cancer	1.15e-06	7.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—liver cancer	1.13e-06	7.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—liver cancer	1.13e-06	7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—liver cancer	1.1e-06	6.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—liver cancer	1.1e-06	6.82e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—liver cancer	1.07e-06	6.63e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—liver cancer	1.07e-06	6.61e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—liver cancer	1.02e-06	6.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—liver cancer	1.01e-06	6.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—liver cancer	9.87e-07	6.12e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—liver cancer	9.69e-07	6.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—liver cancer	9.51e-07	5.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—liver cancer	9.36e-07	5.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—liver cancer	9.34e-07	5.79e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—liver cancer	9.07e-07	5.62e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—liver cancer	8.65e-07	5.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—liver cancer	8.39e-07	5.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—liver cancer	8.03e-07	4.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—liver cancer	7.95e-07	4.93e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—liver cancer	7.92e-07	4.91e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—liver cancer	7.77e-07	4.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—liver cancer	7.69e-07	4.77e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—liver cancer	7.59e-07	4.71e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—liver cancer	7.41e-07	4.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—liver cancer	7.35e-07	4.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—liver cancer	7.04e-07	4.36e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—liver cancer	6.49e-07	4.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—liver cancer	6.2e-07	3.85e-05	CbGpPWpGaD
